We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Hydrogenetics Inc (CE) | USOTC:HYGN | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
The company has delivered over half the contract and expects to deliver the remaining contract ahead of schedule. This one contract alone will gross BBD $137,000 by the end of April.
CEO Charles Hansen commented, "In this challenging business environment BBD has demonstrated its ability to show growth month over month. We are working with some of the top tier Biodiesel companies in North America and we plan to expand our operations aggressively."
Buffalo Biodiesel's 2008 unaudited financial statements reflect $1,750,000 on revenues with approximately $300,000 net profit. HydroGenetics, Inc. will initiate an audit in order to become a fully reporting 34 Act company immediately.
BBD has some exciting events upcoming and the company will continue to update our shareholders as events unfold.
About HydroGenetics, Inc.
HydroGenetics, Inc. is an alternative energy company. The company's mission is to acquire and develop alternative and "green" technology companies into revenue producing, profitable businesses, utilizing investment capital and other resources including management and strategic planning to increase shareholder value. HydroGenetics, Inc.'s wholly owned subsidiary, HydroAxis Technologies, Inc., is currently developing "green hydrogen generating technology systems for any internal combustion engine," which will significantly reduce gasoline consumption in existing and new vehicles.
Forward-Looking Statements
Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements.
Contact: Mark Balbirer 305-573-0821
1 Year Hydrogenetics (CE) Chart |
1 Month Hydrogenetics (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions